Search results
Results from the WOW.Com Content Network
It’s easier than ever for doctors to prescribe a key medicine for opioid addiction since the U.S. government lifted an obstacle last year. But despite the looser restrictions and the ongoing ...
Dr. Robert Newman, a longtime advocate for the use of methadone to treat heroin addiction, was quoted in the Times article as saying that buprenorphine “is associated with a large number of deaths.” Reached by HuffPost, he said the Times story was harmful to those in the recovery community. “I am not an expert in buprenorphine,” he said.
As of 2012, the most recent year for which federal data were available, just 13 states had enough doctors certified to prescribe buprenorphine to their addicted residents, according to a study published in August in the American Journal of Public Health.
Drug overdose deaths in the US per 100,000 people by state. [1] [2] A two milligram dose of fentanyl powder (on pencil tip) is a lethal amount for most people.[3]The United States Centers for Disease Control and Prevention (CDC) has data on drug overdose death rates and totals.
Post-acute withdrawal syndrome (PAWS) is a hypothesized set of persistent impairments that occur after withdrawal from alcohol, [1] [2] opiates, benzodiazepines, barbiturates, and other substances. [ 3 ] [ 4 ] [ 5 ] Infants born to mothers who used substances of dependence during pregnancy may also experience a PAWS.
Although there were 11,882 patients who received at least one narcotic preparation, there were only four cases of reasonably well documented addiction in patients who had no history of addiction. The addiction was considered major in only one instance. The drugs implicated were meperidine in two patients, Percodan in one, and hydromorphone in one.
All available studies collected in the 2005 Australian National Evaluation of Pharmacotherapies for Opioid Dependence suggest that maintenance treatment is preferable, [22] with very high rates (79–100%) [22] of relapse within three months of detoxification from levo-α-acetylmethadol , buprenorphine, and methadone. [22] [23]
Additionally, there is evidence that gender moderates the effect of family, school and peer factors on adolescent substance use. [8] For example, some studies report that not living with both biological parents or having poor parent-adolescent communication is associated with substance use, especially in female adolescents. [9] [10]